CRISPR opens the door to targeted therapy against glioblastoma (Review)

The progression in molecular understanding of glioblastoma (GBM) enables the identification of key therapeutic targets, allowing the advances of targeted therapy in GBM. However, to date, most clinical trial results have been disappointing. The clustered regularly interspaced short palindromic repeats (CRISPR) system is a revolutionary genome‑editing tool that has the potential to improve basic research and therapy for GBM. In the present review, the current status and challenges of targeted therapy in GBM are examined. As a potential approach to address the challenges, the development process and application scope of CRISPR are investigated. Furthermore, the application of CRISPR in the study of GBM is explored, mainly by conducting CRISPR screens and employing CRISPR to target genes associated with the malignant phenotype of GBM. Finally, delivery of CRISPR/CRISPR‑associated protein 9 (Cas9) for the treatment of GBM is briefly reviewed.

Authors

Institutions

Publication Details

Journal
International Journal of Oncology
Published
2026-11-12
DOI
https://doi.org/10.3892/ijo.2026.5957
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CRISPR opens the door to targeted therapy against glioblastoma (Review)

Nachuan Song, Chi Yao, Le Zhang, Chunzhi Zhang et al.
International Journal of Oncology
Glioma Diagnosis and Treatment
article

CRISPR opens the door to targeted therapy against glioblastoma (Review)

Nachuan Song, Chi Yao, Le Zhang, Chunzhi Zhang, Yunying Zhao, Yixin Zhang
article en

Abstract

The progression in molecular understanding of glioblastoma (GBM) enables the identification of key therapeutic targets, allowing the advances of targeted therapy in GBM. However, to date, most clinical trial results have been disappointing. The clustered regularly interspaced short palindromic repeats (CRISPR) system is a revolutionary genome‑editing tool that has the potential to improve basic research and therapy for GBM. In the present review, the current status and challenges of targeted therapy in GBM are examined. As a potential approach to address the challenges, the development process and application scope of CRISPR are investigated. Furthermore, the application of CRISPR in the study of GBM is explored, mainly by conducting CRISPR screens and employing CRISPR to target genes associated with the malignant phenotype of GBM. Finally, delivery of CRISPR/CRISPR‑associated protein 9 (Cas9) for the treatment of GBM is briefly reviewed.

International Journal of OncologyVol. 69(6)
Tianjin University (CN), Tianjin Hospital (CN)
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon